May 19, 2022 7:20am EDT NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. Global Investment Conference
May 16, 2022 7:12am EDT NRx Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
May 12, 2022 8:17am EDT NRx Pharmaceuticals Announces Enrollment of First Patient in Phase II Study of Bipolar Depression with Sub-Acute Suicidality
Apr 21, 2022 8:48am EDT NRx Pharmaceuticals Files New Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil) in Subgroup of Patients with Critical COVID-19 with Respiratory Failure that were also treated with Remdesivir and continued to progress
Apr 08, 2022 8:57am EDT NRx Pharmaceuticals' Interim CEO and other Leaders to Present at 21st Annual Needham Virtual Healthcare Conference
Mar 31, 2022 8:17am EDT NRx Pharmaceuticals Provides Business Update and Reports Full Year 2021 Financial Results
Mar 18, 2022 5:00am EDT NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer
